| Source: |
| Type: measurement |
| Bioavailability (usually in %) absorbed by the body. |
| 8831- | DIM, | 3,3′-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans |
| - | Human, | Nor, | NA |
| 8832- | DIM, | Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy |
| - | Trial, | Pca, | NA |
| 8833- | DIM, | A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer |
| - | Trial, | Pca, | NA |
| 8853- | DIM, | Chemopreventive properties of 3,3′-diindolylmethane in breast cancer: evidence from experimental and human studies |
| - | Review, | Var, | NA |
| 8845- | DIM, | I3C, | 3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways |
| - | Review, | Var, | NA |
| 8844- | DIM, | I3C, | Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 6288- | DL, | From Citrus to Clinic: Limonene’s Journey Through Preclinical Research, Clinical Trials, and Formulation Innovations |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6281- | DL, | Applications of Limonene in Neoplasms and Non-Neoplastic Diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Diabetic, | NA |
| 6363- | DRE, | Therapeutic Potential of Dandelion (Taraxacum officinale) Root Extract in Colon Cancer: A Comprehensive Review |
| - | in-vitro, | CRC, | NA |
| 4914- | DSF, | immuno, | Disulfiram and cancer immunotherapy: Advanced nano-delivery systems and potential therapeutic strategies |
| - | Review, | Var, | NA |
| 5011- | DSF, | Cu, | Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens |
| - | Review, | Var, | NA |
| 5012- | DSF, | Cu, | Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems |
| - | Review, | Var, | NA |
| 4832- | EA, | Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid |
| - | Review, | Var, | NA |
| 1605- | EA, | Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence |
| - | Review, | Var, | NA |
| 1608- | EA, | Ellagic Acid from Hull Blackberries: Extraction, Purification, and Potential Anticancer Activity |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | HUVECs |
| 1611- | EA, | Targeting Myeloperoxidase Activity and Neutrophil ROS Production to Modulate Redox Process: Effect of Ellagic Acid and Analogues |
| - | in-vitro, | Mal, | NA |
| 1615- | EA, | Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers |
| - | Human, | Nor, | NA |
| 6801- | EA, | A radiotherapeutic paradox: ellagic acid sensitizes tumors while attenuating radiation-induced myocardial injury |
| - | vitro+vivo, | BC, | 4T1 |
| 6604- | Ech, | Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion |
| - | Human, | Nor, | NA |
| 7222- | EGb 761, | Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use |
| - | Review, | AD, | NA |
| 3201- | EGCG, | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
| - | Review, | Var, | NA |
| 3593- | EGCG, | Epigallocatechin Gallate (EGCG) |
| - | Review, | AD, | NA |
| 6780- | EGCG, | The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review |
| - | Review, | AD, | NA |
| 6779- | EGCG, | Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review |
| - | Review, | AD, | NA |
| 6783- | EGCG, | Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate |
| - | Review, | Nor, | NA |
| 6782- | EGCG, | Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability |
| - | Human, | Nor, | NA |
| 6789- | EGCG, | Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises? |
| - | Review, | Var, | NA |
| 6785- | EGCG, | Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment |
| - | Review, | Var, | NA |
| 6784- | EGCG, | Dietary (−)-Epigallocatechin Gallate (EGCG): State-of-the-Art Advances in Bioactivities, Bioavailability Enhancement Strategies, and Applications in Nutrition and Health |
| - | Review, | Nor, | NA |
| 2994- | EGCG, | Nano-Engineered Epigallocatechin Gallate (EGCG) Delivery Systems: Overcoming Bioavailability Barriers to Unlock Clinical Potential in Cancer Therapy |
| - | Review, | Var, | NA |
| 1516- | EGCG, | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
| - | Review, | Var, | NA |
| 648- | EGCG, | Bioavailability of Epigallocatechin Gallate Administered With Different Nutritional Strategies in Healthy Volunteers |
| - | Human, | Nor, | NA |
| 647- | EGCG, | Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans |
| - | Human, | Nor, | NA |
| 646- | EGCG, | PI, | Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice |
| - | in-vivo, | Nor, | NA |
| 644- | EGCG, | Citrate, | Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations |
| - | Analysis, | Nor, | NA |
| 675- | EGCG, | When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy |
| - | Review, | Var, | NA |
| 6049- | EGCG, | SeNPs, | Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity |
| - | Study, | AD, | PC12 |
| 5227- | EMD, | Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy |
| - | vitro+vivo, | Nor, | NA |
| 6819- | EMD, | Recent advances in the therapeutic potential of emodin for human health |
| - | Review, | Nor, | NA |
| 6824- | EMD, | Neuroprotective, Anti-Inflammatory and Antifibrillogenic Offerings by Emodin against Alzheimer’s Dementia: A Systematic Review |
| - | Review, | AD, | NA |
| 6823- | EMD, | Role of emodin to prevent gastrointestinal cancers: recent trends and future prospective |
| - | Review, | Var, | NA |
| 6831- | EMD, | PI, | Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats |
| - | in-vivo, | Nor, | NA |
| 6836- | EMD, | Emodin and the Anthraquinone Scaffold: Therapeutic Promise and Strategies to Overcome Translational Barriers |
| - | Review, | Nor, | NA |
| 6814- | EMD, | Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics |
| - | Review, | Nor, | NA |
| 1324- | EMD, | Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin |
| - | Review, | Var, | NA |
| 5256- | EP, | Pulsed electric fields: a sharp sword in the battle against cancers |
| - | Review, | Var, | NA |
| 6581- | EU, | Bioavailability of Eurycomanone in Its Pure Form and in a Standardised Eurycoma longifolia Water Extract |
| - | in-vitro, | Colon, | Caco-2 | - | in-vivo, | Nor, | NA |
| 6383- | Eug, | In Vitro Incorporation of Radioiodinated Eugenol on Adenocarcinoma Cell Lines (Caco2, MCF7, and PC3) |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Pca, | PC3 |
| 6381- | Eug, | Biological Properties and Prospects for the Application of Eugenol—A Review |
| - | Review, | Var, | NA |
| 6389- | Eug, | Molecular Insights into the Management of Eugenol's Anticancer Action Against Colon Cancer: A Detailed Review |
| - | Review, | Colon, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:792 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid